Screening for colorectal cancer in African Americans: determinants and rationale for an earlier age to commence screening.
Screening for colorectal cancer in African Americans: determinants and rationale for an earlier age to commence screening.
复制标题
DOI:
10.1007/s10620-014-3443-5
复制
发表时间:
2015-03
影响因子:
3.1
通讯作者:
Carethers, John M.
中科院分区:
文献类型:
--
作者:
Carethers, John M.
Colorectal cancer (CRC) screening is a highly cost-effective approach to reduce morbidity and mortality of patients, as well as reduce the prevalence of CRC in populations. Current recommendations for CRC screening for the asymptomatic general population begin at age 50 years, an age after which ~95% of cancers occur. Determinants that modify the timing and frequency for screening include a personal or family history of adenomatous polyps or CRC, the age of onset of these colonic lesions, and the presence or potential for a patient to harbor a higher-risk syndrome such as inflammatory bowel disease (IBD), familial adenomatous polyposis (FAP), or Lynch syndrome.. Although race, like family history, is a heritable factor, it has not engendered inclusion in the same broad systematic screening recommendations despite multiple studies demonstrating a disparity in the incidence and mortality from CRC, and the potential for targeted screening to reduce the disparity. In particular, African Americans, when compared to Caucasians, (a) have lower CRC screening utilization rates, (b) have an earlier presentation of CRC (0-8 years younger than Caucasians) and, more often have aggressive biological features more prone to metastasis, (c) have a higher CRC prevalence at all ages and a higher proportion of CRCs before 50 years of age (~11% vs 5% in Caucasians), (d) are less likely to know or transmit personal or family history of adenomas or CRC that might change their screening to an earlier age, (e) present with 7-15% excess right-sided CRCs that are not microsatellite unstable, (f) show higher frequencies of high-risk adenomas at every decile of age, and an excess of high-risk proximal adenomas that mirror the excess of proximal CRCs, (g) have cancers that demonstrate lower proportions of good prognostic biomarkers such as MSI and higher proportions of bad prognosticators such as EMAST, (h) may possess gut microbiota more conducive to initiating and/or propagating colonic neoplasia, and (i) may demonstrate worse outcomes with treatment for CRC. These epidemiological, biological, and genetic parameters put African Americans at higher risk from CRC irrespective of any socioeconomic issues, much like IBD, FAP, and Lynch syndrome patients. Including race as a factor to consider in national CRC screening guidelines, such as commencing screening at an earlier age than 50 years, seems rational based on the natural history and more aggressive behavior in this population.
登录
查看更多内容
影响因子:
29.4
作者:
Boland CR;Goel A
通讯作者:
Goel A
影响因子:
12.6
作者:
Carethers, John M.
通讯作者:
Carethers, John M.
DOI:
10.1158/1055-9965.epi-13-0143
发表时间:
2013-06
期刊:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子:
--
作者:
Andaya AA;Enewold L;Zahm SH;Shriver CD;Stojadinovic A;McGlynn KA;Zhu K
通讯作者:
Zhu K
影响因子:
3.7
作者:
Carethers, John M.;Murali, Bhavya;McGuire, Kathleen L.
通讯作者:
McGuire, Kathleen L.
DOI:
10.1007/s11605-010-1340-6
发表时间:
2010-10
期刊:
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
影响因子:
--
作者:
Devaraj B;Lee A;Cabrera BL;Miyai K;Luo L;Ramamoorthy S;Keku T;Sandler RS;McGuire KL;Carethers JM
通讯作者:
Carethers JM